Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP

Journal of Molecular Biology

Volumn 329, Issue 4, 2003, Pages 699-710

  Ahmadian, Mohammad Reza ^a   Kiel, Christina ^a   Stege, Patricia ^a   Scheffzek, Klaus ^b  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

GAP; Neurofibromin; NF1; p120GAP; Ras

Indexed keywords

ARGININE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LEUCINE; LYSINE; NEUROFIBROMIN; PHENYLALANINE;

AMINO ACID ANALYSIS; ARTICLE; CATALYSIS; COMPARATIVE STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME MECHANISM; FLUORESCENCE; HYDROPHOBICITY; MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0038054300     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00514-X     Document Type: Article

References (69)

1. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 348:1990;125-132.
2. Vetter I.R., Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science. 294:2001;1299-1304.
3. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
4. Abrams S.I., Hand P.H., Tsang K.Y., Schlom J. Mutant ras epitopes as targets for cancer vaccines. Sem. Oncol. 23:1996;118-134.
5. Wittinghofer A. Signal transduction via Ras. Biol. Chem. 379:1998;933-937.
6. Der C.J., Finkel T., Cooper G.M. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell. 44:1986;167-176.
7. Seeburg P.H., Colby W.W., Capon D.J., Goeddel D.V., Levinson A.D. Biological properties of human c-Ha-ras 1 genes mutated at codon 12. Nature. 312:1984;71-75.
8. Scheffzek K., Ahmadian M.R., Wittinghofer A. GTPase-activating proteins: helping hands to complement an active site. Trends Biochem. Sci. 23:1998;257-262.
9. Cichowski K., Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 104:2001;593-604.
10. Xu G., O'Connel P., Viskochil D., Cawthon R., Robertson M., Culver M., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 62:1990;599-608.
11. Donovan S., Shannon K.M., Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. Biochim. Biophys. Acta. 1602:2002;23-45.
12. Trahey M., McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science. 238:1987;542-545.
13. Trahey M., Wong G., Halenbeck R., Rubinfeld B., Martin G.A., Ladner M., et al. Molecular cloning of two types of GAP complementary DNA from human placenta. Science. 242:1988;1697-1700.
14. Vogel U., Dixon R.A.F., Schaber M.D., Diehl R.E., Marshall M.S., Scolnick E.M., et al. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature. 335:1988;90-93.
15. Soncini C., Berdo I., Draetta G. Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease. Oncogene. 20:2001;3869-3879.
16. Koehler J.A., Moran M.F. Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation. Cell Growth Differ. 12:2001;551-561.
17. Chow A., Davis A.J., Gawler D.J. Investigating the role played by protein-lipid and protein-protein interactions in the membrane association of the p120GAP CaLB domain. Cell Signal. 11:1999;443-451.
18. Henkemeyer M., Rossi D.J., Holmyard D.P., Puri M.C., Mbamalu G., Harpal K., et al. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature. 377:1995;695-701.
19. Brodeur G.M. The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. N. Engl. J. Med. 330:1994;637-639.
20. Guha A., Lau N., Huvar I., Gutmann D., Provias J., Pawson T., Boss G. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene. 12:1996;507-513.
21. Andersen L.B., Ballester R., Marchuk D.A., Chang E., Gutmann D.H., Saulino A.M., et al. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which hae GTPase-activating protein activity. Mol. Cell. Biol. 13:1993;487-495.
22. Costa R.M., Yang T., Huynh D.P., Pulst S.M., Viskochil D.H., Silva A.J., Brannan C.I. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nature Genet. 27:2001;399-405.
23. Costa R.M., Federov N.B., Kogan J.H., Murphy G.G., Stern J., Ohno M., et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 415:2002;526-530.
24. Gideon P., John J., Frech M., Lautwein A., Clark R., Scheffler J.E., Wittinghofer A. Mutational and kinetic analysis of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity. Mol. Cell. Biol. 12:1992;2050-2056.
25. Bryant S.S., Mitchell A.L., Collins F., Miao W., Marshall M., Jove R. N-terminal sequences contained in the Src homology 2 and 3 domains of p120 GTPase-activating protein are required for full catalytic activity toward Ras. J. Biol. Chem. 271:1996;5195-5199.
26. Drugan J.K., Rogers-Graham K., Gilmer T., Campbell S., Clark G.J. The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain. J. Biol. Chem. 275:2002;35021-35027.
27. Bollag G., McCormick F., Clark R. Characterization of full-length neurofibromin: tubulin inhibits ras GAP activity. EMBO J. 12:1993;1923-1927.
28. Ahmadian M.R., Hoffmann U., Goody R.S., Wittinghofer A. Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry. 36:1997;4535-4541.
29. Wiesmüller L., Wittinghofer A. Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in E. coli and role of the conserved lysine residue. J. Biol. Chem. 267:1992;10207-10210.
30. Eccleston J.F., Moore K.J.M., Morgan L., Skinner R.H., Lowe P.N. Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, p120-GAP and neurofibromin. J. Biol. Chem. 268:1993;27012-27019.
31. Nixon A.E., Brune M., Lowe P.N., Webb M. Kinetics of inorganic phosphate release during the interaction of p21ras with the GTPase-activating proteins p120-GAP and neurofibromin. Biochemistry. 34:1995;15592-15598.
32. Mittal R., Ahmadian M.R., Goody R.S., Wittinghofer A. Formation of a transition state analog of the Ras GTPase reaction by Ras·GDP, tetrafluoroaluminate and GTPase-activating proteins. Science. 273:1996;115-117.
33. Ahmadian M.R., Mittal R., Hall A., Wittinghofer A. Formation of a transition state analogue of the GTPase reaction between small GTP-binding proteins and their GAPs. FEBS Letters. 408:1997;315-318.
34. Wittinghofer A. Signaling mechanistics: aluminum fluoride for molecule of the year. Curr. Biol. 7:1997;R682-R685.
35. Resat H., Straatsma T.P., Dixon D.A., Miller J.H. The arginine finger of RasGAP helps Gln-61 align the nucleophilic water in GAP-stimulated hydrolysis of GTP. Proc. Natl Acad. Sci. USA. 98:2001;6033-6038.
36. Scheffzek K., Ahmadian M.R., Kabsch W., Wiesmüller L., Lautwein A., Schmitz F., Wittinghofer A. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 277:1997;333-338.
37. Ahmadian M.R., Stege P., Scheffzek K., Wittinghofer A. Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nature Struct. Biol. 4:1997;686-689.
38. Scheffzek K., Lautwein A., Kabsch W., Ahmadian M.R., Wittinghofer A. Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature. 384:1996;591-596.
39. Scheffzek K., Ahmadian M.R., Wiesmüller L., Kabsch W., Stege P., Schmitz F., Wittinghofer A. Structural analysis of the GAP related domain from neurofibromin and its implications. EMBO J. 17:1998;4313-4327.
40. Gutmann D.H., Boguski M., Marchuk D., Wigler M., Collins F.S., Ballester R. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene. 8:1993;761-769.
41. Miao W., Eichelberger L., Baker L., Marshall M.S. p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues. J. Biol. Chem. 271:1996;15322-15329.
42. Rittinger K., Walker P.A., Eccleston J.F., Smerdon S.J., Gamblin S.J. Structure at 1.65 Å of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature. 389:1997;758-762.
43. Parrini M.C., Bernardi A., Parmeggiani A. Determinants of Ras proteins specifying the sensitivity to yeast Ira2p and human p120-GAP. EMBO J. 15:1996;107-111.
44. te Biesebeke R., Krab I.M., Parmeggiani A. The arginine finger loop of yeast and human GAP is a determinant for the specificity toward Ras GTPase. Biochemistry. 40:2001;7474-7479.
45. Klose A., Ahmadian M.R., Schülke M., Scheffzek K., Hoffmeyer S., Gewies A., et al. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1). Human. Mol. Genetics. 7:1998;1261-1268.
46. N-ras catalyzed by GAP: studies with a fluorescent GTP analogue. Biochemistry. 32:1993;7451-7459.
47. Skinner R.H., Bradley S., Brown A.L., Johnson N.J.E., Rhodes S., Stammers D.K., Lowe P.N. Use of the Glu-Glu-Phe C-terminal epitope for rapid purification of the catalytic domain of normal and mutant ras GTPase-activating proteins. J. Biol. Chem. 266:1991;14163-14166.
48. ras measured by a novel fluorescence anisotropy method. J. Biol. Chem. 268:1993;10914-10919.
49. Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., et al. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell. 69:1992;275-281.
50. Upadhyaya M., Osborn M.J., Maynard J., Kim M.R., Tamanoi F., Cooper D.N. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum. Genet. 99:1997;88-92.
51. Morcos P., Thapar N., Tusneem N., Stacey D., Tamanoi F. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol. Cell. Biol. 16:1996;2496-2503.
52. Nakafuku M., Nagamine M., Ohtoshi A., Tanaka K., Toh-e A., Kaziro Y. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions. Proc. Natl Acad. Sci. USA. 90:1993;6706-6710.
53. Brannan C.I., Perkins A.S., Vogel K.S., Ratner N., Nordlund M.L., Reid W., et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1994;1019-1029.
54. Jacks T., Shih T.S., Schmitt E.M., Bronson R.T., Bernards A., Weinberg R.A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet. 7:1994;353-361.
55. Gaul U., Mardon G., Rubin G.M. A putative ras GTPase activating protein acts as a negative regulator of signalling by the sevenless receptor tyrosine kinase. Cell. 68:1992;1007-1019.
56. The I., Hannigan G.E., Cowley G.S., Reginald S., Zhong Y., Gusella J.F., et al. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science. 276:1997;791-794.
57. Mollat P., Fournier A., Yang C.Z., Alsat E., Zhang Y., Evain-Brion D., et al. Species specificity and organ, cellular and subcellular localization of the 100 kDa Ras GTPase activating protein. J. Cell Sci. 107:1994;427-435.
58. Hiatt K.K., Ingram D.A., Zhang Y., Bollag G., Clapp D.W. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells. J. Biol. Chem. 276:2001;7240-7245.
59. Klebe C., Bischoff F.R., Ponstingl H., Wittinghofer A. Interaction of the nuclear GTP-binding protein Ran with its regulatory proteins RCC1 and RanGAP1. Biochemistry. 34:1995;639-647.
60. Seewald M.J., Körner C., Wittinghofer A., Vetter I.R. RanGAP mediates GTP hydrolysis without an arginine finger. Nature. 415:2002;662-666.
61. Brinkmann T., Daumke O., Herbrand U., Kühlmann D., Stege P., Ahmadian M.R., Wittinghofer A. Rap-specific GTPase activating protein follows an alternative mechanism. J. Biol. Chem. 277:2002;12525-12531.
62. Pai E.F., Krengel U., Petsko G.A., Goody R.S., Kabsch W., Wittinghofer A. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 Å resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 9:1990;2351-2359.
63. Milburn M.V., Tong L., DeVos A.M., Brünger A., Yamaizumi Z., Nishimura S., Kim S.-H. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science. 247:1990;939-945.
64. Kraulis P.J., Domaille P.J., Campbell-Burk S.L., Van Aken T., Laue E.D. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry. 33:1994;3515-3531.
65. Tucker J., Sczakiel G., Feuerstein J., John J., Goody R.S., Wittinghofer A. Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J. 5:1986;1351-1358.
66. Ahmadian M.R., Wiesmuller L., Lautwein A., Bischoff F.R., Wittinghofer A. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J. Biol. Chem. 271:1996;16409-16415.
67. John J., Sohmen R., Feuerstein J., Linke R., Wittinghofer A., Goody R.S. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry. 29:1990;6058-6065.
68. Ahmadian M.R., Zor T., Vogt D., Kabsch W., Selinger Z., Wittinghofer A., Scheffzek K. Guanosine triphosphatase stimulation of oncogenic Ras mutants. Proc. Natl Acad. Sci. USA. 96:1999;7065-7070.
69. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;281-296.